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THE USE OF ECONOMIC EVALUATION IN A MEDICAL DEVICE 
COMMISION OF AN ITALIAN TEACHING HOSPITAL
Alello A, Bassotto F, Filippi C, Fratucello A, Ghirlanda G, Marini P, Scroccaro G, Fantelli V
Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy
OBJECTIVES: In order to control Medical Devices (MDs) purchasing process and to 
rationalize the MDs evaluation process, the Verona Hospitals (2 accounting for 1.700 
beds), have set up a Medical Devices Committee (MDC). MDC members, who have 
expertise in a broad range of disciplines, evaluate MDs according to Health Technol-
ogy Assessment (HTA) criteria. This study is concerned with the use of economic 
evaluations in policy decision making of MDC. METHODS: We developed a Data-
Base to record all economic evidences considered by MDC from January 2009 to April 
2010 for each MD evaluated: health economics analysis in literature (cost-effective-
ness, cost-to-cost etc), cost information (price, costs impact etc) and Disease Related 
Group (DRG) simulation. We veriﬁ ed also the presence and costs of current alternative 
treatments. RESULTS: Among 37 MDs evaluated 30 technologies had at least a 
current alternative treatment in Hospital formulary (81.1%); MDC always considered 
at least the price of MDs, costs impact of introducing a new MD and costs when 
compared with alternative/current treatments (100%). For 23 MDs the management 
ofﬁ ce individuated the DRG value (62.2%) and for 12 of them (32.4%) veriﬁ ed 
whether DRG covered direct costs. Only for 4 MDs (10.8%) was possible ﬁ nding at 
least an economic study in literature (2 cost-effectiveness analysis and 2 cost-to-cost 
analysis). CONCLUSIONS: At the moment the decisions taken by the MDC mainly 
focused on the clinical beneﬁ ts, on the comparison of costs vs. alternative treatments 
and on the incidence of the DM cost on the DRG tariff. The economic evidences 
seldom inﬂ uence the opinion of MDC, most of all because the clinical value of DM 
is not always supported by economic evidences. Recently, technology application form 
has been modiﬁ ed including questions about the potential savings derived by the new 
technology, economic studies (also not published) and Budget Impact analysis.
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VALUE OF MULTI-CRITERIA DECISION ANALYSIS IN EARLY 
ASSESSMENT OF MEDICAL DIAGNOSTIC DEVICES
Ijzerman MJ, Hummel J
University Twente, Enschede, The Netherlands
OBJECTIVES: Multicriteria decision analytic (MCDA) techniques are a powerful tool 
in evaluating health care interventions where multiple, often competing, factors need 
to be considered. The analytic hierarchy process (AHP) is one such technique. We 
have applied AHP to evaluate medical diagnostic technologies as to support product 
development and market access. The main objective of this study is to show feasibility 
of AHP in terms of applicability and outcome. We therefore have studied the expected 
performance of the Photoacoustic Mammoscope (PAM), a new imaging device for 
detection of breast cancer based on photoacoustic imaging. METHODS: Before start-
ing the study we deﬁ ned different diagnostic and screening scenarios for the PAM 
including criteria that are important in the acceptance of the device. We ﬁ nally deﬁ ned 
four strategies including mammography, ultrasound and MRI imaging. The Analytic 
Hierarchy Process (AHP) analysis was then used to identify the relative importance 
of evaluation criteria, and to identify the relative performance of four different breast 
cancer imaging techniques. RESULTS: According to the expert panel the most impor-
tant criterion in the design of a diagnostic breast imaging device is sensitivity (overall 
weight was 54%). Factors that mainly determine the performance on sensitivity are 
the visualization of mass margins, mass shape and vascularization. Second most 
important criterion was safety. CONCLUSIONS: From an early assessment of pho-
toacoustic imaging it may be concluded that the potential clinical performance justiﬁ es 
further development and implementation of PAM. However, further research on the 
use of AHP in medical product development is required. We present and discuss some 
ideas to further integrate clinical evidence into MCDA using Bayesian techniques as 
well as sensitivity analyses on the model inputs.
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PERSONALIZED PHARMACOTHERAPY AND ANALYSIS OF 
EXTEMPORANEOUS DOSAGE FORMS FOR CHILDREN IN UKRAINE
Maynych Y, Zalis’ka O
Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
OBJECTIVES: Pharmacotherapy of children requires the use of drugs for individual 
preparation of personalized treatment. Medications extemporal manufacturing 
approach allows for Personalized Medicine. The use of extemporaneous preparations 
to precisely match the appropriate concentration of drug forms, volume and available 
dosage forms for komplayensu, extemporaneous medicines do not contain stabilizers, 
preservatives, it is important for children with allergic diseases. METHODS: The 
ABC—analysis was conducted of 3525 prescription extemporaneous preparations 
which were made in 8 pharmacies specialized of Western Ukraine regions for 2007–
2009. RESULTS: The total list of pediatric formulations consisted of 106 items. 
Determined that the practical range of medicines includes 7 extemporaneous dosage 
forms, including solutions of 45% solutions, ointments 23% and 12% suspensions et 
al. Revealed that the production of extemporaneous preparations seasonal inﬂ uences. 
Increasing production of liquids, powders at the time of respiratory exacerbation in 
children. Distinguished set of extemporaneous preparations, which are often assigned 
practical pediatrician in Ukraine: protargol drops—when rhinitis, cough mixture, 
powder euﬁ linu with glucose—with bronchitis, Foenuculi water—with ﬂ atulence, 
pepsin solution with hydrochloric acid—in violation of appetite, anestezynum suspen-
sion; dexamethasone ointment, betamethasone ointment—for allergies vitamin 
powder. Determined extemporaneous medicines for children, which have no ana-
logues in industrial production—a solution of pepsin with hydrochloric acid, dexa-
methasone ointment, paste Lassara with oil Plum; diazolinum powder with calcium 
gluconate and glucose—from allergies, suppositories with cocoa butter and levomit-
setinum—with diarrhea, Foenuculi water—with ﬂ atulence in newborns and infants. 
CONCLUSIONS: Using drugs extemporal medicines, namely those that have no 
industrial counterparts, to ensure individualized pharmacotherapy children pick up 
the dose, volume of product, and prevent undesirable side reactions, especially for 
treatment of chronic diseases in children with allergic manifestations and provide a 
personalized therapy in pediatric practice.
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IMPACT OF BLEEDING-RELATED CONSEQUENCES ON LENGTH OF 
STAY (LOS) AND HOSPITAL COSTS IN PATIENTS UNDERGOING 
SURGERY IN FRANCE
Lafuma A1, Ye X2, Torreton E1, Bastide P3, Arnaud A3
1CEMKA-EVAL, Bourg la Reine, France; 2Ethicon, a Johnson & Johnson Company, Somerville, 
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OBJECTIVES: The objectives of this study were to estimate the incidence, costs and 
length of stay (LOS) of bleeding-related consequences in various surgical procedures 
in France. METHODS: A retrospective analysis was conducted using the national 
Diagnosis Related Group (DRG) database (PMSI). Patients with surgical procedures 
in 2008 were identiﬁ ed based on DRGs. For each DRG, the rate of bleeding-related 
consequences was estimated. For DRGs with an incidence of bleeding-related conse-
quences over 10%, age and gender-adjusted hospital LOS and costs were examined 
among patients with (WB) and without bleeding related consequences (WoB). The 
rates of hospitalizations exceeding the expected LOS (derived from PMSI) between 
WB and WoB surgeries were compared using multivariate logistic regression. 
RESULTS: Of the 88 different DRGs in French database, 24 (a total of 321,657 
hospitalizations) had an incidence of bleeding-related consequences over 10%, ranging 
from 10.3% to 25.3%. DRGs with higher rates were transplantations, cardiac and 
major orthopedic surgery, vascular and solid organ surgery. Age and gender adjusted 
mean LOS for WB patients was 3.38 days longer (+26.5%) compared with WoB 
patients (P < 0.001). Average adjusted costs were estimated at c12,087 per WB stays 
versus c10,086 per WoB stays, corresponding to a 19.9% increase (P < 0.001). The 
rate of hospitalizations exceeding the expected LOS was respectively 42.3 % and 
37.0% for WB and WoB hospitalizations (P < 0.001). WB hospitalizations were 
approximately 10% more likely to exceed expected LOS compared to WoB (OR = 
1.09, 95% CI: 1.07–1.11, P < 0.001), after adjusting for patient characteristics. 
CONCLUSIONS: This study characterizes the increased hospital LOS and cost among 
patients with bleeding-related consequences in France. In particular, the excess LOS 
than expected DRG LOS presents signiﬁ cant ﬁ nancial burden related to bleeding 
consequences for hospitals. Awareness of potential clinical and economic impacts of 
bleeding-related consequences provides important framework for understanding the 
value of blood-conservation strategies.
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OBJECTIVES: We examined the effects of chronic stress with modelling different shift 
work schedules in animal experimental model. METHODS: Internationally most 
frequently used night shift schedules were applied in three groups of animals 
(4DL/3LD; 8DL/6LD; 2DL/2LD) beside a group kept in normal LD cycle (12 hour 
light-L/12 hour dark-D = control group). Groups were divided in two parts, one of 
them were exposed to CMS. Degree of anxiety was evaluated in light-dark box. Dif-
ferences between groups according to variables (sex, lighting regimens and CMS) and 
time spent in light, number of changing compartments and latency of changing dark 
to the light section were examined with multiple one-way analysis of variance. Plasma 
concentrations of corticosterone and testosterone were measured after 4 weeks of 
exposure to stress procedures, concentrations were determined by radioimmunoassay. 
RESULTS: In groups kept under different lighting schedules compared to control 
group, signiﬁ cant differences were found: animals kept in 4DL/3LD (p = 0.05, p = 
0.079 /nearly signiﬁ cant/ p = 0.011) and 2DL/2LD (p = 0.025, p = 0.001, p = 0.045) 
schedules spent less time in light, latency increased, while no statistically signiﬁ cant 
differences were found in 8DL/6LD group in any of the variables (p = 0.113, p = 
0.118, p = 0.45). We found that groups kept in different lighting schedules and 
exposed to chronic stress kept their circadian rhythm (corticosterone: p = 0,095—
border line statistical signiﬁ cance; testosterone: p = 0.004), while groups kept in dif-
ferent lighting schedules but not exposed to chronic stress lost circadian rhythms 
(corticosterone: p = 0.071 for 12-hour component; testosterone: p > 0.20). CONCLU-
SIONS: According to light-dark box test and hormonal examinations it seems, that 
shifts different than normal light/dark regimen lead to anxiety also without CMS, and 
may have been harder load than the CMS procedure. Group 8DL/6LD shows the 
closest approximations of parameters observed in LD group suggesting that this 
schedule applied in shift work is less harmful to health, and provides the best way of 
regeneration. 
